Biotech firm: Graphcore IPUs faster for AI-based drug discovery than GPUs

In the race to provide the best machine-learning accelerators, one of Nvidia's top challengers has claimed a victory in the biotech space, London firm LabGenius, which said Graphcore's intelligence processing units (IPUs) provide significantly faster performance for AI-based drug discovery than some unidentified traditional GPUs …

[Pascal Monett]

LabGenius

Soon to be bought by Nvidia.

[Steve K]

Re: LabGenius

You old cynic....;-)

(Or maybe AMD?)

[elwe]

Re: LabGenius

Probably Intel, as they want to compete in the space. But they will be run down to useless by Intel and tossed aside...

[Snowy]

Re: LabGenius

Or Intel.

While they are call Graphcore they do not produce graphics card. That they produce somethings that is designed to do "AI" work is better than a GPU is not much of a surprise.